The Growing Family of Limb-Girdle Muscular Dystrophies: Old and Newly Identified Members

1. WICKLUND MP, KISSEL JT. The limb-girdle muscular dystrophies. Neurol Clin 2014; 32(3): 729-49.10.1016/j.ncl.2014.04.00525037088Search in Google Scholar

2. WALTON J, NATRASS F. On the classification, natural history and treatment of the myopathies. Brain. 1954; 77:169-231.10.1093/brain/77.2.16913190076Search in Google Scholar

3. BARESI R. From proteins to genes: immunoanalysis in the diagnosis of muscular dystrophies. Skeletal Muscle. 2011; 1:24.10.1186/2044-5040-1-24315664721798100Search in Google Scholar

4. MAHMOOD O, JIANG XM. Limb-girdle muscular dystrophies: Where next after six decades from the first proposal. Mol Med Rep, 2014; 9(5): 1515-1532.10.3892/mmr.2014.2048402049524626787Search in Google Scholar

5. NIGRO V, SAVARESE M. Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myologica 2014; 32: 1-12.Search in Google Scholar

6. COTTA A, CARVALHO E, LOPES DA-CUNHA A, et al. Common recessive limb girdle muscular dystrophies differential diagnosis: why and how? Arq Neuropsiquiatr, 2014; 72(9): 721-734.10.1590/0004-282X20140110Search in Google Scholar

7. NORWOOD FL, HARLING C, CHINNERY PF, EAGLE M, BUSHBY K, STRAUB V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009; 132: 3175-3186.10.1093/brain/awp236403849119767415Search in Google Scholar

8. GOMEZ-DIAZ B, ROSAS-VARGAS H, ROQUE-RAMIREZ B, et al. Immunodetection analysis of muscular dystrophies in Mexico. Muscle Nerve. 2012; 45: 338-345.10.1002/mus.2231422334167Search in Google Scholar

9. DINIZ G, ERYAŞAR G, TÜRE S, et al. A regional panorama of dysferlinopathies. Turk Patoloji Derg. 2012; 28: 259-265.10.5146/tjpath.2012.0113323011829Search in Google Scholar

10. FANIN M, NASCIMBENI AC, FULIZIO L, et al. The frequency of limb girdle muscular dystrophy 2A in northeastern Italy. Neuromuscul Disord 2005; 15:218-24.10.1016/j.nmd.2004.11.00315725583Search in Google Scholar

11. STEHLÍKOVÁ K, SKÁLOVÁ D, ZÍDKOVÁ J, MRÁZOVÁL, MAZANEC R, VOHANKA S, HABERLOVA J, HERMANOVA M, ZAMECNIK J, SOUCEK O, OŠLEJŠKOVÁ H, DVOŘÁČKOVÁ N, SOLAROVA P, FAJKUSOVÁ L. Autosomal recessive limb-girdle muscular dystrophies in the Czech Republic. BMC Neurology 2014, 14:154.10.1186/s12883-014-0154-7414525025135358Search in Google Scholar

12. ZATZ M, DE PAULA F, STARLING A, VAINZOF M. The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromuscular disorders, 2003; 13: 532-544.10.1016/S0960-8966(03)00100-7Search in Google Scholar

13. PENISSON-BESNIER I, HACKMAN P, SUOMINEN T, et al. Myopathies caused by homozygous titin mutations: limb-girdle muscular dystrophy 2J and variations of phenotype. J Neurol Neurosurg Psychiatry 2010; 81:1200-2.10.1136/jnnp.2009.17843420571043Search in Google Scholar

14. HALLIDAY W, GREENBERG CR, WROGEMANN K, et al. Genetic heterogeneity of limb girdle muscular dystrophy in Manitoba Hutterites. Am J Hum Genet 1998; 63 (Suppl): A 392.Search in Google Scholar

15. SHOKEIR MH, KOBRINSKY NL. Autosomal recessive muscular dystrophy in Manitoba Hutterites. Clin Genet. 1976; 9(2): 197-202.Search in Google Scholar

16. WEILER T, GREENBERG CR, ZELINSKI T, et al. Limb Girdle Muscular Dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another LGMD locus. Am J Hum Genet. 1998; 63: 140-7.10.1086/30192513772469634523Search in Google Scholar

17. REILICH P, KRAUSE S, SCHRAMM N, et al. A novel mutation in the myotilin gene (MYOT) causes a severe form of limb girdle muscular dystrophy 1A (LGMD1A). J Neurol 2011; 258:1437-44.10.1007/s00415-011-5953-921336781Search in Google Scholar

18. HAUSER MA, HORRIGAN SK, SALMIKANGAS P, et al. Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet, 2000; 9:2141-7.10.1093/hmg/9.14.214110958653Search in Google Scholar

19. SALMIKANGAS P, VAN DER VEN PF, LALOWSKI M, TAIVAINEN A, ZHAO F, SUILA H, SCHRÖDER R, LAPPALAINEN P, FÜRST DO, CARPÉN O. Myotilin, the limb-girdle muscular dystrophy 1A (LGMD1A) protein, cross-links actin filaments and controls sarcomere assembly. Hum Mol Genet. 2003; 12(2): 189-203.10.1093/hmg/ddg02012499399Search in Google Scholar

20. MUCHIR A, BONNE G, VAN DER KOOI AJ, et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb-girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 2000; 9:1453-9.10.1093/hmg/9.9.145310814726Search in Google Scholar

21. LAVAL SH, BUSHBY KM. Limb-girdle muscular dystrophies-from genetics to molecular pathology. Neuropathol Appl Neurobiol. 2004; 30(2):91-105.10.1111/j.1365-2990.2004.00555.x15043707Search in Google Scholar

22. POLITANO L, CARBONI N, MADEJ-PILARCZYK A, et al. Advances in basic and clinical research in laminopathies. Acta Myol, 2013; 32:18-22.Search in Google Scholar

23. COUCHOUX H, BICHRAOUI H, CHOUABE C, ALTAFAJ X, BONVALLET R, ALLARD B, RONJAT M, BERTHIER C. Caveolin-3 is a direct molecular partner of the Cav 1.1 subunit of the skeletal muscle L-type calcium channel. The International Journal of Biochemistry & Cell Biology, 2011; 43 (5): 713-720. 10.1016/j.biocel.2011.01.01121262376Search in Google Scholar

24. GAZZERRO E, SOTGIA F, BRUNO C, LISANTI MP, MINETTI C. Caveolinopathies: from the biology of caveolin-3 to human diseases. European Journal of Human Genetics. 2010; 18: 137-145.10.1038/ejhg.2009.103298718319584897Search in Google Scholar

25. LO HP, BERTINI E, MIRABELLA M, DOMAZETOVSKA A, DALE RC, PETRINI S, D’AMICO A, VALENTE EM, BARRESI R, ROBERTS M, TOZZI G, TASCA G, COOPER ST, et al. Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies. Neuromuscular Disorders, 2011; 21 (3): 194-203.10.1016/j.nmd.2010.11.01521295981Search in Google Scholar

26. MINETTI C, SOTGIA F, BRUNO C, SCARTEZZINI P, BRODA P, BADO M, MASETTI E, MAZZOCCO M, EGEO A, DONATI M A, VOLONTÉ D, GALBIATI F, CORDONE G, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nature Genetics, 1998; 18: 365-368.10.1038/ng0498-3659537420Search in Google Scholar

27. CARBONE I, BRUNO C, SOTGIA F, BADO M, BRODA P, MASETTI E, PANELLA A, ZARA F, BRICARELLI FD, CORDONE G, LISANTI MP, MINETTI C. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology.2000; 54(6):1373-6.10.1212/WNL.54.6.137310746614Search in Google Scholar

28. MERLINI L, CARBONE I, CAPANNI C, SABATELLI P, TORTORELLI S, LISANTI MP, BRUNO C, MINETTI C. Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry. 2002; 73(1):65-7.10.1136/jnnp.73.1.65175730512082049Search in Google Scholar

29. WOODMAN SE, SOTGIA F, GALBIATI F, MINETTI C, LISANTI MP. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology.2004 ; 62(4): 538-43.10.1212/WNL.62.4.538Search in Google Scholar

30. PETERLE E, FANIN M, SEMPLICINI C, et al. Clinical phenotype, muscle MRI and muscle pathology of LGMD1F. J Neurol, 2013; 260:2033-41.10.1007/s00415-013-6931-123632945Search in Google Scholar

31. VIEIRA NM, NASLAVSKY MS, LICINIO L, et al. A defect in the RNAprocessing protein HNRPDL causes limb-girdle muscular dystrophy1G (LGMD1G). Hum Mol Genet 2014. [Epub ahead of print]10.1093/hmg/ddu12724647604Search in Google Scholar

32. STARLING A, KOK F, PASSOS-BUENO MR, et al. A new form of autosomal dominant limb-girdle muscular dystrophy (LGMD1G) with progressive fingers and toes flexion limitation maps to chromosome 4p21. Eur J Hum Genet 2004; 12: 1033-40.10.1038/sj.ejhg.520128915367920Search in Google Scholar

33. BISCEGLIA L, ZOCCOLELLA S, TORRACO A, et al. A new locus on 3p23-p25 for an autosomal-dominant limb-girdle muscular dystrophy, LGMD1H. Eur J Hum Genet 2010; 18: 636-41.10.1038/ejhg.2009.235298733620068593Search in Google Scholar

34. FARDEAU M, HILLAIRE D, MIGNARD C, FEINGOLD N, FEINGOLD J, MIGNARD D, DE UBEDA B, COLLIN H, TOME FM, RICHARD I, BECKMANN J. Juvenile limb-girdle muscular dystrophy: clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain 1996; 119: 295-308.10.1093/brain/119.1.2958624690Search in Google Scholar

35. PATHAK P, SHARMA MC, SARKAR C, et al. Limb-girdle muscular dystrophy type 2A in India: a study based on semiquantitative protein analysis, with clinical and histopathological correlation. Neurol India, 2010; 58: 549-54.10.4103/0028-3886.68675Search in Google Scholar

36. WEILER T, BASHIR R, ANDERSON LV, et al. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene (s). Hum Mol Genet, 1999; 8:871-7.10.1093/hmg/8.5.871Search in Google Scholar

37. CACCIOTTOLO M, NUMITONE G, AURINO S, et al. Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations. Eur J Hum Genet. 2011; 19:974-80.10.1038/ejhg.2011.70Search in Google Scholar

38. NOGUCHI S, MCNALLY EM, BEN OTHMANE K, et al. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome13 muscular dystrophy. Science. 1995; 270:819-22.10.1126/science.270.5237.819Search in Google Scholar

39. LIM LE, DUCLOS F, BROUX O, et al. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet. 1995; 11:257-65.10.1038/ng1195-257Search in Google Scholar

40. ROBERDS SL, LETURCQ F, ALLAMAND V, et al. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 1994; 78:625-33.10.1016/0092-8674(94)90527-4Search in Google Scholar

41. MOREIRA ES, WILTSHIRE TJ, FAULKNER G, et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet 2000; 24:163-6.10.1038/7282210655062Search in Google Scholar

42. LOCKE M, TINSLEY CL, BENSON MA, et al. TRIM32 is an E3 ubiquitin ligase for dysbindin. Hum Mol Genet 2009; 18:2344-58.10.1093/hmg/ddp167269468619349376Search in Google Scholar

43. FROSK P, WEILER T, NYLEN E, et al. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet 2002; 70: 663-72.10.1086/33908344762111822024Search in Google Scholar

44. BROWN SC, TORELLI S, BROCKINGTON M, YUVA Y, JIMENEZ C, FENG L, ANDERSON L, UGO I, KROGER S, BUSHBY K, VOIT T, SEWRY C, MUNTONI F. Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies, American Journal of Pathology, 2004, 164 (2):727-37.Search in Google Scholar

45. LIANG W-C, HAYASHI YK, OGAWA M, WANG C-H, HUANG W-T, NISHINO I, JONG Y-J. Limb-girdle muscular dystrophy type 2I is not rare in Taiwan. Neuromuscular Disorders, 2013, 23 (8): 675-681.10.1016/j.nmd.2013.05.01023800702Search in Google Scholar

46. BROCKINGTON M, BLAKE DJ, PRANDINI P, et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet, 2001; 69:1198-209.10.1086/324412123555911592034Search in Google Scholar

47. MERCURI E, BROCKINGTON M, STRAUB V, et al. Phenotypic spectrum associated with mutations in the fukutin-related protein gene. AnnNeurol, 2003; 53:537-42.10.1002/ana.1055912666124Search in Google Scholar

48. GERULL B, GRAMLICH M, ATHERTON J, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002; 30:201-4.10.1038/ng81511788824Search in Google Scholar

49. CHONG YK, KWAN MA LC, LO KL, LAI LEE CK, MAK CM, CHI KAN AN, LAM CW. Dystroglycanopathy with two novel POMT1 mutations in a Chinese boy with developmental delay and muscular dystrophy. European Journal of Paediatric Neurology, 2014 [Epub ahead of print].10.1016/j.ejpn.2014.03.00324657014Search in Google Scholar

50. BEHIN A, LETURCQ F, COSSÉE M, WAHBI K, DEBURGRAVE N, BÉCANE H-M, CARLIER R-Y, LAFORÊT P, STOJKOVIC T, CARLIER P, EYMARD B. Anoctamin 5 myopathy: More patients, more phenotypes. Journal of the Neurological Sciences, 2013, 333 (Suppl. 1): e47. 10.1016/j.jns.2013.07.1598Search in Google Scholar

51. BOLDUC V, MARLOW G, BOYCOTT KM, SALEKI K, INOUE H, KROON J, ITAKURA M, ROBITAILLE Y, PARENT L, BAAS F, et al. Recessive Mutations in the Putative Calcium-Activated Chloride Channel Anoctamin 5 Cause Proximal LGMD2L and Distal MMD3 Muscular Dystrophies. The American Journal of Human Genetics. 2010; 86:213-221.10.1016/j.ajhg.2009.12.013282017020096397Search in Google Scholar

52. BOUQUET F, COSSEE M, BEHIN A, DEBURGRAVE N, ROMERO N, LETURCQ F, EYMARD B. Miyoshi-like distal myopathy with mutations in anoctamin 5 gene (Myopathie de type Miyoshi associée à des mutations du gène de l’anoctamine 5). Revue Neurologique. 2012; 168 (2): 135-141.10.1016/j.neurol.2011.10.00522336395Search in Google Scholar

53. HICKS D, SARKOZY A, MUELAS N, KÖEHLER K, HUEBNER A, HUDSON G, CHINNERY PF, BARRESI R, EAGLE M, et al. A founder mutation in Anoctamin 5 is a major cause of limb girdle muscular dystrophy. Brain. 2011; 134 (1): 171-182.10.1093/brain/awq294403851221186264Search in Google Scholar

54. LITTLE A, MCKEEVER P, GRUIS K. Novel mutations in the anoctamin 5 gene (ANO5) associated with limb-girdle muscular dystrophy 2L. Muscle & Nerve, 2013; 47 (2): 287-291.10.1002/mus.2354223169617Search in Google Scholar

55. MAGRI F, DEL BO R, D’ANGELO MG, SCIACCO M, GANDOSSINI S, GOVONI A, NAPOLI L, CISCATO P, et al. Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients. Neuromuscular Disorders, 2012; 22 (11): 934-943.10.1016/j.nmd.2012.05.001350069222742934Search in Google Scholar

56. MAHJNEH I, JAISWAL J, LAMMINEN A, SOMER M, MARLOW G, KIURU-ENARI S, BASHIR R. A new distal myopathy with mutation in anoctamin 5. Neuromuscular Disorders, 2010; 20 (12): 791-795.10.1016/j.nmd.2010.07.270420677620692837Search in Google Scholar

57. RAJ JOSHI P, GLÄSER D, DREßEL C, KRESS W, WEIS J, DESCHAUER M. Anoctamin 5 muscular dystrophy associated with a silent p.Leu115Leu mutation resulting in exon skipping. Neuromuscular Disorders, 2014; 24 (1): 43-47.10.1016/j.nmd.2013.09.00324239059Search in Google Scholar

58. SARKOZY A, HICKS D, HUDSON J, LAVAL SH, BARRESI R, HILTON-JONES D, DESCHAUER M, HARRIS E, et al. ANO5 Gene Analysis in a Large Cohort of Patients with Anoctaminopathy: Confirmation of Male Prevalence and High Occurrence of the Common Exon 5 Gene Mutation. Human Mutation. 2013; 34 (8): 1111-1118.10.1002/humu.2234223606453Search in Google Scholar

59. SCHESSL J, KRESS W, SCHOSER B. Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy, 2012; Muscle & Nerve, 45 (5): 740-742.10.1002/mus.2328122499103Search in Google Scholar

60. WAHL CM, VAN GHELUE M, ARNTZEN KA, HALVORSEN H, INGEBRIGTSEN M, SKOGSTAD A, HESTHOLM B, LØSETH S, MELLGREN SI, RASMUSSEN F, LINDAHL S, JONSRUD C. Mutations in anoctamin 5 in limb girdle muscular dystrophy in Norway: Phenotypic variability and mutation spectrum. Journal of the Neurological Sciences, 2013; 333 (SUPPL. 1): E444.10.1016/j.jns.2013.07.1589Search in Google Scholar

61. WITTING N, DUNO M, PETRI H, KRAG T, BUNDGAARD H, KOBER L, VISSING J. Anoctamin 5 muscular dystrophy in Denmark: prevalence, genotypes, phenotypes, cardiac findings, and muscle protein expression. Journal of Neurology, 2013; 260 (8): 2084-2093.10.1007/s00415-013-6934-y23670307Search in Google Scholar

62. TIAN Y, SCHREIBER R, KUNZELMANN K. Anoctamins are a family of Ca2+-activated Cl- channels. J Cell Sci; 125:4991-8.Search in Google Scholar

63. MERCURI E, MESSINA S, BRUNO C, et al. Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology, 2009; 72: 1802-9.10.1212/01.wnl.0000346518.68110.6019299310Search in Google Scholar

64. PUCKETT RL, MOORE SA, WINDER TL, et al. Further evidence of Fukutin mutations as a cause of childhood onset limbgirdle muscular dystrophy without mental retardation. Neuromuscul Disord, 2009; 19:352-6.10.1016/j.nmd.2009.03.001269859319342235Search in Google Scholar

65. BIANCHERI R, FALACE A, TESSA A, et al. POMT2 gene mutation in limb-girdle muscular dystrophy with inflammatory changes. Biochem Biophys Res Commun, 2007; 363:1033-7.10.1016/j.bbrc.2007.09.06617923109Search in Google Scholar

66. PANE M, MESSINA S, VASCO G, FOLEY AR, MORANDI L, PEGORARO E, MONGINI T, D’AMICO A, BIANCO F, LOMBARDO ME, SCALISE R, BRUNO C, BERARDINELLI A, et al. Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency. Neuromuscular Disorders, 2012; 22 (8): 685-689.10.1016/j.nmd.2012.05.006347653222727687Search in Google Scholar

67. CLEMENT EM, GODFREY C, TAN J, et al. Mild POMGNT1 mutations underlie a novel limb-girdle muscular dystrophy variant. Arch Neurol, 2008; 65:137-41.10.1001/archneurol.2007.218195152Search in Google Scholar

68. RADUCU M, BAETS J, FANO O, et al. Promoter alteration causes transcriptional repression of the POMGNT1 gene in limbgirdle muscular dystrophy type 20. Eur J Hum Genet, 2012.10.1038/ejhg.2012.40342112522419172Search in Google Scholar

69. GODFREY C, FOLEY AR, CLEMENT E, MUNTONI F. Dystroglycanopathies: coming into focus, Current Opinion in Genetics & Development. 2011; 21 (3): 278-285.Search in Google Scholar

70. HARA Y, BALCI-HAYTA B, YOSHIDA-MORIGUCHI T, KANAGAWA M, BELTRÁN-VALERO DE BERNABÉ D, GÜNDEŞLI H, WILLER T, SATZ JS, CRAWFORD RW, et al. A Dystroglycan Mutation Associated with Limb-Girdle Muscular Dystrophy. New Engl. J. Med. 2011; 364(10): 939-946.Search in Google Scholar

71. GUNDESLI H, TALIM B, KORKUSUZ P, et al. Mutation in exon 1f of PLEC, leading to disruption of plectin isoform 1f, causes autosomal-recessive limb-girdle muscular dystrophy. Am J Hum Genet 2010; 87:834-41.10.1016/j.ajhg.2010.10.017299737321109228Search in Google Scholar

72. CETIN N, BALCI-HAYTA B, GUNDESLI H, et al. A novel desmin mutation leading to autosomal recessive limb-girdle muscular dystrophy: distinct histopathological outcomes compared with desminopathies. J Med Genet 2013; 50:437-43.10.1136/jmedgenet-2012-10148723687351Search in Google Scholar

73. BOGERSHAUSEN N, SHAHRZAD N, CHONG JX, et al. Recessive TRAPPC11 mutations cause a disease spectrum of limb girdle musculardystrophy and myopathy with movement disorder and intellectual disability. Am J Hum Genet; 93:181-90. 87:834-41.10.1016/j.ajhg.2013.05.028371075723830518Search in Google Scholar

74. SCRIVENS PJ, SHAHRZAD N, MOORES A, et al. TRAPPC2L is a novel, highly conserved TRAPP-interacting protein. Traffic 2009; 10:724-36.10.1111/j.1600-0854.2009.00906.x19416478Search in Google Scholar

75. CARSS KJ, STEVENS E, FOLEY AR, CIRAK, RIEMERSMA M, TORELLI S, HOISCHEN A, WILLER T, VAN SCHERPENZEEL M, MOORE SA, et al. Mutations in GDP-Mannose Pyrophosphorylase B Cause Congenital and Limb- Girdle Muscular Dystrophies Associated with Hypoglycosylation of α-Dystroglycan. The American Journal of Human Genetics. 2013; 93 (1): 29-41.10.1016/j.ajhg.2013.05.009371076823768512Search in Google Scholar

76. CIRAK S, FOLEY AR, HERRMANN R, WILLER T, YAU S, STEVENS E, TORELLI S, BRODD L, KAMYNINA A, VONDRACEK P, ROPER H, LONGMAN C, KORINTHENBERG R. et al. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain 2013; 136(1): 269-281. 10.1093/brain/aws312356207623288328Search in Google Scholar

77. GUGLIERI M, BUSHBY K. How to go about diagnosing and managing the limb-girdle muscular dystrophies. Neurol India, 2008; 56: 271-80.10.4103/0028-3886.4344518974553Search in Google Scholar

78. WICKLUND MP, KISSEL JT. The limb-girdle muscular dystrophies. Neurol Clin 2014; 32(3):729-49.10.1016/j.ncl.2014.04.00525037088Search in Google Scholar

79. WALTON J, NATRASS F. On the classification, natural history and treatment of the myopathies. Brain. 1954; 77:169-231.10.1093/brain/77.2.169Search in Google Scholar

80. BARESI R. From proteins to genes: immunoanalysis in the diagnosis of muscular dystrophies. Skeletal Muscle. 2011; 1:24.10.1186/2044-5040-1-24Search in Google Scholar

81. MAHMOOD O, JIANG XM. Limb-girdle muscular dystrophies: Where next after six decades from the first proposal. Mol Med Rep, 2014; 9(5): 1515-1532.10.3892/mmr.2014.2048Search in Google Scholar

82. NIGRO V, SAVARESE M. Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myologica 2014; 32: 1-12.Search in Google Scholar

83. COTTA A, CARVALHO E, LOPES DA-CUNHA A, et al. Common recessive limb girdle muscular dystrophies differential diagnosis: why and how? Arq Neuropsiquiatr, 2014; 72(9):721-734.10.1590/0004-282X20140110Search in Google Scholar

84. NORWOOD FL, HARLING C, CHINNERY PF, EAGLE M, BUSHBY K, STRAUB V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009; 132:3175-3186.10.1093/brain/awp236Search in Google Scholar

85. GOMEZ-DIAZ B, ROSAS-VARGAS H, ROQUE-RAMIREZ B, et al. Immunodetection analysis of muscular dystrophies in Mexico. Muscle Nerve. 2012; 45:338-345.10.1002/mus.22314Search in Google Scholar

86. DINIZ G, ERYAŞAR G, TÜRE S, et al. A regional panorama of dysferlinopathies. Turk Patoloji Derg. 2012; 28: 259-265.10.5146/tjpath.2012.01133Search in Google Scholar

87. FANIN M, NASCIMBENI AC, FULIZIO L, et al. The frequency of limb girdle muscular dystrophy 2A in northeastern Italy. Neuromuscul Disord 2005; 15:218-24.10.1016/j.nmd.2004.11.003Search in Google Scholar

88. STEHLÍKOVÁ K, SKÁLOVÁ D, ZÍDKOVÁ J, MRÁZOVÁ L, MAZANEC R, VOHANKA S, HABERLOVA J, HERMANOVA M, ZAMECNIK J, SOUCEK O, OŠLEJŠKOVÁ H, DVOŘÁČKOVÁ N, SOLAROVA P, FAJKUSOVÁ L. Autosomal recessive limb-girdle muscular dystrophies in the Czech Republic. BMC Neurology 2014, 14:154.10.1186/s12883-014-0154-7Search in Google Scholar

89. ZATZ M, DE PAULA F, STARLING A, VAINZOF M. The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromuscular disorders, 2003; 13: 532-544.10.1016/S0960-8966(03)00100-7Search in Google Scholar

90. PENISSON-BESNIER I, HACKMAN P, SUOMINEN T, et al. Myopathies caused by homozygous titin mutations: limb-girdle muscular dystrophy 2J and variations of phenotype. J Neurol Neurosurg Psychiatry 2010; 81:1200-2.10.1136/jnnp.2009.17843420571043Search in Google Scholar

91. HALLIDAY W, GREENBERG CR, WROGEMANN K, et al. Genetic heterogeneity of limb girdle muscular dystrophy in Manitoba Hutterites. Am J Hum Genet 1998; 63 (Suppl): A 392.Search in Google Scholar

92. SHOKEIR MH, KOBRINSKY NL. Autosomal recessive muscular dystrophy in Manitoba Hutterites. Clin Genet. 1976; 9(2): 197-202.Search in Google Scholar

93. WEILER T, GREENBERG CR, ZELINSKI T, et al. Limb Girdle Muscular Dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another LGMD locus. Am J Hum Genet. 1998; 63: 140-7.10.1086/30192513772469634523Search in Google Scholar

94. REILICH P, KRAUSE S, SCHRAMM N, et al. A novel mutation in the myotilin gene (MYOT) causes a severe form of limb girdle muscular dystrophy 1A (LGMD1A). J Neurol 2011; 258:1437-44.10.1007/s00415-011-5953-921336781Search in Google Scholar

95. HAUSER MA, HORRIGAN SK, SALMIKANGAS P, et al. Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet, 2000; 9:2141-7.10.1093/hmg/9.14.214110958653Search in Google Scholar

96. SALMIKANGAS P, VAN DER VEN PF, LALOWSKI M, TAIVAINEN A, ZHAO F, SUILA H, SCHRÖDER R, LAPPALAINEN P, FÜRST DO, CARPÉN O. Myotilin, the limb-girdle muscular dystrophy 1A (LGMD1A) protein, cross-links actin filaments and controls sarcomere assembly. Hum Mol Genet. 2003; 12(2): 189-203.10.1093/hmg/ddg02012499399Search in Google Scholar

97. MUCHIR A, BONNE G, VAN DER KOOI AJ, et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limbgirdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 2000; 9:1453-9.10.1093/hmg/9.9.145310814726Search in Google Scholar

98. LAVAL SH, BUSHBY KM. Limb-girdle muscular dystrophies-from genetics to molecular pathology. Neuropathol Appl Neurobiol.2004; 30(2): 91-105.10.1111/j.1365-2990.2004.00555.x15043707Search in Google Scholar

99. POLITANO L, CARBONI N, MADEJ-PILARCZYK A, et al. Advances in basic and clinical research in laminopathies. Acta Myol, 2013; 32:18-22.Search in Google Scholar

100. COUCHOUX H, BICHRAOUI H, CHOUABE C, ALTAFAJ X, BONVALLET R, ALLARD B, RONJAT M, BERTHIER C. Caveolin-3 is a direct molecular partner of the Cav 1.1 subunit of the skeletal muscle L-type calcium channel. The International Journal of Biochemistry & Cell Biology, 2011; 43 (5): 713-720.10.1016/j.biocel.2011.01.01121262376Search in Google Scholar

101. GAZZERRO E, SOTGIA F, BRUNO C, LISANTI MP, MINETTI C. Caveolinopathies: from the biology of caveolin-3 to human diseases. European Journal of Human Genetics. 2010; 18: 137-145.10.1038/ejhg.2009.103298718319584897Search in Google Scholar

102. LO HP, BERTINI E, MIRABELLA M, DOMAZETOVSKA A, DALE RC, PETRINI S, D’AMICO A, VALENTE EM, BARRESI R, ROBERTS M, TOZZI G, TASCA G, COOPER ST, et al. Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies. Neuromuscular Disorders, 2011; 21 (3): 194-203.10.1016/j.nmd.2010.11.01521295981Search in Google Scholar

103. MINETTI C, SOTGIA F, BRUNO C, SCARTEZZINI P, BRODA P, BADO M, MASETTI E, MAZZOCCO M, EGEO A, DONATI M A, VOLONTÉ D, GALBIATI F, CORDONE G, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nature Genetics, 1998; 18: 365-368.10.1038/ng0498-3659537420Search in Google Scholar

104. CARBONE I, BRUNO C, SOTGIA F, BADO M, BRODA P, MASETTI E, PANELLA A, ZARA F, BRICARELLI FD, CORDONE G, LISANTI MP, MINETTI C. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology. 2000; 54(6):1373-6.10.1212/WNL.54.6.137310746614Search in Google Scholar

105. MERLINI L, CARBONE I, CAPANNI C, SABATELLI P, TORTORELLI S, LISANTI MP, BRUNO C, MINETTI C. Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry. 2002; 73(1):65-7.10.1136/jnnp.73.1.65175730512082049Search in Google Scholar

106. WOODMAN SE, SOTGIA F, GALBIATI F, MINETTI C, LISANTI MP. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology.2004 ; 62(4):538-43. 10.1212/WNL.62.4.538Search in Google Scholar

107. PETERLE E, FANIN M, SEMPLICINI C, et al. Clinical phenotype, muscle MRI and muscle pathology of LGMD1F. J Neurol, 2013; 260:2033-41.10.1007/s00415-013-6931-123632945Search in Google Scholar

108. VIEIRA NM, NASLAVSKY MS, LICINIO L, et al. A defect in the RNA processing protein HNRPDL causes limb-girdle muscular dystrophy1G (LGMD1G). Hum Mol Genet 2014 [Epub ahead of print].10.1093/hmg/ddu12724647604Search in Google Scholar

109. STARLING A, KOK F, PASSOS-BUENO MR, et al. A new form of autosomal dominant limb-girdle muscular dystrophy (LGMD1G) with progressive fingers and toes flexion limitation maps to chromosome 4p21. Eur J Hum Genet 2004; 12: 1033-40.10.1038/sj.ejhg.520128915367920Search in Google Scholar

110. BISCEGLIA L, ZOCCOLELLA S, TORRACO A, et al. A new locus on 3p23-p25 for an autosomal-dominant limb-girdle muscular dystrophy, LGMD1H. Eur J Hum Genet 2010; 18: 636-41.10.1038/ejhg.2009.235298733620068593Search in Google Scholar

111. FARDEAU M, HILLAIRE D, MIGNARD C, FEINGOLD N, FEINGOLD J, MIGNARD D, DE UBEDA B, COLLIN H, TOME FM, RICHARD I, BECKMANN J. Juvenile limb-girdle muscular dystrophy: clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain 1996; 119: 295-308.10.1093/brain/119.1.2958624690Search in Google Scholar

112. PATHAK P, SHARMA MC, SARKAR C, et al. Limb girdle muscular dystrophy type 2A in India: a study based on semiquantitative protein analysis, with clinical and histopathological correlation. Neurol India, 2010; 58:549-54.10.4103/0028-3886.6867520739790Search in Google Scholar

113. WEILER T, BASHIR R, ANDERSON LV, et al. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene (s). Hum Mol Genet, 1999; 8:871-7.10.1093/hmg/8.5.871Search in Google Scholar

114. CACCIOTTOLO M, NUMITONE G, AURINO S, et al. Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations. Eur J Hum Genet. 2011; 19:974-80.10.1038/ejhg.2011.70Search in Google Scholar

115. NOGUCHI S, MCNALLY EM, BEN OTHMANE K, et al. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome13 muscular dystrophy. Science. 1995; 270:819-22.10.1126/science.270.5237.819Search in Google Scholar

116. LIM LE, DUCLOS F, BROUX O, et al. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet. 1995; 11:257-65.10.1038/ng1195-257Search in Google Scholar

117. ROBERDS SL, LETURCQ F, ALLAMAND V, et al. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 1994; 78:625-33.10.1016/0092-8674(94)90527-4Search in Google Scholar

118. MOREIRA ES, WILTSHIRE TJ, FAULKNER G, et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet 2000;24:163-6.10.1038/72822Search in Google Scholar

119. LOCKE M, TINSLEY CL, BENSON MA, et al. TRIM32 is an E3 ubiquitin ligase for dysbindin. Hum Mol Genet 2009; 18:2344-58.10.1093/hmg/ddp167Search in Google Scholar

120. FROSK P, WEILER T, NYLEN E, et al. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet 2002; 70: 663-72.10.1086/339083Search in Google Scholar

121. BROWN SC, TORELLI S, BROCKINGTON M, YUVA Y, JIMENEZ C, FENG L, ANDERSON L, UGO I, KROGER S, BUSHBY K, VOIT T, SEWRY C, MUNTONI F. Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies. American Journal of Pathology, 2004, 164 (2):727-37.10.1016/S0002-9440(10)63160-4Search in Google Scholar

122. LIANG W-C, HAYASHI YK, OGAWA M, WANG C-H, HUANG W-T, NISHINO I, JONG Y-J. Limb-girdle muscular dystrophy type 2I is not rare in Taiwan, Neuromuscular Disorders, 2013, 23 (8): 675-681.Search in Google Scholar

123. BROCKINGTON M, BLAKE DJ, PRANDINI P, et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet, 2001; 69:1198-209.10.1086/324412123555911592034Search in Google Scholar

124. MERCURI E, BROCKINGTON M, STRAUB V, et al. Phenotypic spectrum associated with mutations in the fukutin-related protein gene. AnnNeurol, 2003; 53:537-42.10.1002/ana.1055912666124Search in Google Scholar

125. GERULL B, GRAMLICH M, ATHERTON J, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy,Nat Genet 2002; 30:201-4.Search in Google Scholar

126. CHONG YK, KWAN MA LC, LO KL, LAI LEE CK, MAK CM, CHI KAN AN, LAM CW. Dystroglycanopathy with two novel POMT1 mutations in a Chinese boy with developmental delay and muscular dystrophy. European Journal of Paediatric Neurology, 2014 [Epub ahead of print].10.1016/j.ejpn.2014.03.00324657014Search in Google Scholar

127. BEHIN A, LETURCQ F, COSSÉE M, WAHBI K, DEBURGRAVE N, BÉCANE H-M, CARLIER R-Y, LAFORÊT P, STOJKOVIC T, CARLIER P, EYMARD B. Anoctamin 5 myopathy: More patients, more phenotypes. Journal of the Neurological Sciences, 2013, 333 (Suppl. 1): e47.10.1016/j.jns.2013.07.1598Search in Google Scholar

128. BOLDUC V, MARLOW G, BOYCOTT KM, SALEKI K, INOUE H., KROON J, ITAKURA M, ROBITAILLE Y, PARENT L, BAAS F, et al. Recessive Mutations in the Putative Calcium-Activated Chloride Channel Anoctamin 5 Cause Proximal LGMD2L and Distal MMD3 Muscular Dystrophies. The American Journal of Human Genetics. 2010; 86:213-221.10.1016/j.ajhg.2009.12.013282017020096397Search in Google Scholar

129. BOUQUET F, COSSEE M, BEHIN A, DEBURGRAVE N, ROMERO N, LETURCQ F, EYMARD B. Miyoshi-like distal myopathy with mutations in anoctamin 5 gene (Myopathie de type Miyoshi associée à des mutations du gène de l’anoctamine 5). Revue Neurologique. 2012; 168 (2): 135-141.10.1016/j.neurol.2011.10.00522336395Search in Google Scholar

130. HICKS D, SARKOZY A, MUELAS N, KÖEHLER K, HUEBNER A, HUDSON G, CHINNERY PF, BARRESI R, EAGLE M, et al. A founder mutation in Anoctamin 5 is a major cause of limb girdle muscular dystrophy. Brain. 2011; 134 (1): 171-182.10.1093/brain/awq294403851221186264Search in Google Scholar

131. LITTLE A, MCKEEVER P, GRUIS K. Novel mutations in the anoctamin 5 gene (ANO5) associated with limb-girdle muscular dystrophy 2L. Muscle & Nerve, 2013; 47 (2): 287-291.10.1002/mus.2354223169617Search in Google Scholar

132. MAGRI F, DEL BO R, D’ANGELO MG, SCIACCO M, GANDOSSINI S, GOVONI A, NAPOLI L, CISCATO P, et al. Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients. Neuromuscular Disorders, 2012; 22 (11): 934-943.10.1016/j.nmd.2012.05.001350069222742934Search in Google Scholar

133. MAHJNEH I, JAISWAL J, LAMMINEN A, SOMER M, MARLOW G, KIURU-ENARI S, BASHIR R. A new distal myopathy with mutation in anoctamin 5. Neuromuscular Disorders, 2010; 20 (12): 791-795.10.1016/j.nmd.2010.07.270420677620692837Search in Google Scholar

134. RAJ JOSHI P, GLÄSER D, DREßEL C, KRESS W, WEIS J, DESCHAUER M. Anoctamin 5 muscular dystrophy associated with a silent p.Leu115Leu mutation resulting in exon skipping. Neuromuscular Disorders, 2014; 24 (1): 43-47. 10.1016/j.nmd.2013.09.00324239059Search in Google Scholar

135. SARKOZY A, HICKS D, HUDSON J, LAVAL SH, BARRESI R, HILTON-JONES D, DESCHAUER M, HARRIS E, et al. ANO5 Gene Analysis in a Large Cohort of Patients with Anoctaminopathy: Confirmation of Male Prevalence and High Occurrence of the Common Exon 5 Gene Mutation. Human Mutation. 2013; 34 (8): 1111-1118.10.1002/humu.2234223606453Search in Google Scholar

136. SCHESSL J, KRESS W, SCHOSER B. Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy. 2012; Muscle & Nerve, 45 (5): 740-742.Search in Google Scholar

137. WAHL CM, VAN GHELUE M, ARNTZEN KA, HALVORSEN H, INGEBRIGTSEN M, SKOGSTAD A, HESTHOLM B, LØSETH S, MELLGREN SI, RASMUSSEN F, LINDAHL S, JONSRUD C. Mutations in anoctamin 5 in limb girdle muscular dystrophy in Norway: Phenotypic variability and mutation spectrum. Journal of the Neurological Sciences, 2013; 333 (SUPPL. 1): E444.10.1016/j.jns.2013.07.1589Search in Google Scholar

138. WITTING N, DUNO M, PETRI H, KRAG T, BUNDGAARD H, KOBER L, VISSING J. Anoctamin 5 muscular dystrophy in Denmark: prevalence, genotypes, phenotypes, cardiac findings, and muscle protein expression. Journal of Neurology, 2013; 260 (8): 2084-2093.10.1007/s00415-013-6934-y23670307Search in Google Scholar

139. TIAN Y, SCHREIBER R, KUNZELMANN K. Anoctamins are a family of Ca2+-activated Cl- channels. J Cell Sci; 125:4991-8.Search in Google Scholar

140. MERCURI E, MESSINA S, BRUNO C, et al. Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology, 2009;72: 1802-9.10.1212/01.wnl.0000346518.68110.6019299310Search in Google Scholar

141. PUCKETT RL, MOORE SA, WINDER TL, et al. Further evidence of Fukutin mutations as a cause of childhood onset limbgirdle muscular dystrophy without mental retardation. Neuromuscul Disord, 2009;19:352-6.10.1016/j.nmd.2009.03.001269859319342235Search in Google Scholar

142. BIANCHERI R, FALACE A, TESSA A, et al. POMT2 gene mutation in limb-girdle muscular dystrophy with inflammatory changes. Biochem Biophys Res Commun, 2007; 363:1033-7.10.1016/j.bbrc.2007.09.06617923109Search in Google Scholar

143. PANE M, MESSINA S, VASCO G, FOLEY AR, MORANDI L, PEGORARO E, MONGINI T, D’AMICO A, BIANCO F, LOMBARDO ME, SCALISE R., BRUNO C, BERARDINELLI A, et al. Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency. Neuromuscular Disorders, 2012; 22 (8): 685-689.10.1016/j.nmd.2012.05.006347653222727687Search in Google Scholar

144. CLEMENT EM, GODFREY C, TAN J, et al. Mild POMGNT1 mutations underlie a novel limb-girdle muscular dystrophy variant. Arch Neurol, 2008; 65:137-41.10.1001/archneurol.2007.218195152Search in Google Scholar

145. RADUCU M, BAETS J, FANO O, et al. Promoter alteration causes transcriptional repression of the POMGNT1 gene in limbgirdle muscular dystrophy type 20. Eur J Hum Genet, 2012.10.1038/ejhg.2012.40342112522419172Search in Google Scholar

146. GODFREY C, FOLEY AR, CLEMENT E, MUNTONI F. Dystroglycanopathies: coming into focus. Current Opinion in Genetics & Development. 2011; 21 (3): 278-285.10.1016/j.gde.2011.02.00121397493Search in Google Scholar

147. HARA Y, BALCI-HAYTA B, YOSHIDA-MORIGUCHI T, KANAGAWA M, BELTRÁN-VALERO DE BERNABÉ D, GÜNDEŞLI H, WILLER T, SATZ JS, CRAWFORD RW, et al. A Dystroglycan Mutation Associated with Limb-Girdle Muscular Dystrophy. New Engl. J. Med. 2011; 364(10): 939-946.Search in Google Scholar

148. GUNDESLI H, TALIM B, KORKUSUZ P, et al. Mutation in exon 1f of PLEC, leading to disruption of plectin isoform 1f, causes autosomal-recessive limb-girdle muscular dystrophy. Am J Hum Genet 2010; 87:834-41.10.1016/j.ajhg.2010.10.017299737321109228Search in Google Scholar

149. CETIN N, BALCI-HAYTA B, GUNDESLI H, et al. A novel desmin mutation leading to autosomal recessive limb-girdle muscular dystrophy: distinct histopathological outcomes compared with desminopathies. J Med Genet 2013; 50:437-43.10.1136/jmedgenet-2012-10148723687351Search in Google Scholar

150. BOGERSHAUSEN N, SHAHRZAD N, CHONG JX, et al. Recessive TRAPPC11 mutations cause a disease spectrum of limb girdle muscular dystrophy and myopathy with movement disorder and intellectual disability. Am J Hum Genet; 93:181-90. 87:834-41.10.1016/j.ajhg.2013.05.028371075723830518Search in Google Scholar

151. SCRIVENS PJ, SHAHRZAD N, MOORES A, et al. TRAPPC2L is a novel, highly conserved TRAPP-interacting protein. Traffic 2009; 10:724-36.10.1111/j.1600-0854.2009.00906.x19416478Search in Google Scholar

152. CARSS KJ, STEVENS E, FOLEY AR, CIRA K, RIEMERSMA M, TORELLI S, HOISCHEN A, WILLER T, VAN SCHERPENZEEL M, MOORE SA, et al. Mutations in GDP-Mannose Pyrophosphorylase B Cause Congenital and Limb- Girdle Muscular Dystrophies Associated with Hypoglycosylation of α-Dystroglycan. The American Journal of Human Genetics. 2013; 93 (1): 29-41.10.1016/j.ajhg.2013.05.009371076823768512Search in Google Scholar

153. CIRAK S, FOLEY AR, HERRMANN R, WILLER T, YAU S, STEVENS E, TORELLI S, BRODD L, KAMYNINA A, VONDRACEK P, ROPER H, LONGMAN C, KORINTHENBERG R, et al. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain 2013; 136(1): 269-281.10.1093/brain/aws312356207623288328Search in Google Scholar

154. GUGLIERI M, BUSHBY K. How to go about diagnosing and managing the limb-girdle muscular dystrophies. Neurol India, 2008; 56:271-80. 10.4103/0028-3886.4344518974553Search in Google Scholar